黄芪甲苷的药理作用研究进展

被引：270

作者：

蒋微 ^{[1
]}

蒋式骊 ^{[1
]}

刘平 ^{[1
,2
]}

机构：

[1] 上海中医药大学附属曙光医院肝病研究所肝肾疾病病证教育部重点实验室上海市重点实验室

[2] 上海中医药大学交叉科学研究院

来源：

中华中医药学刊 | 2019年 / 37卷 / 09期

基金：

国家自然科学基金重点项目;

关键词：

黄芪甲苷; 黄芪; 药理; 研究综述;

D O I：

暂无

中图分类号：

R285.5 [中药实验药理];

学科分类号：

100806 [中药药理学];

摘要：

黄芪甲苷(AS-IV)为羊毛酯醇形的四环三萜皂苷,是中药黄芪的主要活性成分之一,具有多种生物活性。根据国内外相关文献,详细阐述黄芪甲苷药理作用的研究进展,为黄芪甲苷的进一步研究开发提供依据。

引用

页码：2121 / 2124

页数：4

共 27 条

[1]

Astragaloside IV inhibits TGF‐β1‐induced epithelial‐mesenchymal transition through inhibition of the PI3K/Akt/NF‐κB pathway in gastric cancer cells.[J].Jihong Zhu;Ke Wen.Phytotherapy Research.2018, 7

[2]

Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB.[J].Yaling Li;Yun Ye;Hongyan Chen.Biomedicine & Pharmacotherapy.2018,

[3]

NRF2/HO-1 activation via ERK pathway involved in the anti-neuroinflammatory effect of Astragaloside IV in LPS induced microglial cells.[J].Congjin Li;Fanglin Yang;Feng Liu;Dongbo Li;Tao Yang.Neuroscience Letters.2018,

[4]

Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.[J].Hongli Li;Ping Wang;Fei Huang;Jinmei Jin;Hui Wu;Beibei Zhang;Zhifei Wang;Hailian Shi;Xiaojun Wu.Toxicology and Applied Pharmacology.2018,

[5]

Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting α-synuclein expression via the p38 MAPK pathway [J].

Liu, Xiang ;

Zhang, Jun ;

Wang, Shibo ;

Qiu, Jinfu ;

Yu, Chao .

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (06) :1772-1780

[6]

Astragaloside IV inhibits progression of glioma via blocking MAPK/ERK signaling pathway [J].

Li, Bin ;

Wang, Fei ;

Liu, Ningtao ;

Shen, Wen ;

Huang, Tao .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 491 (01) :98-103

[7]

Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms.[J].Min Li;Hongyan Li;Fang Fang;Xueyang Deng;Shiping Ma.Neuroscience Letters.2017,

[8]

Astragaloside IV rescues MPP+-induced mitochondrial dysfunction through upregulation of methionine sulfoxide reductase A [J].